Alnuctamab, a BCMA x CD3 T-Cell Engager, in Pts with Relapsed/Refractory Multiple Myeloma International Myeloma Foundation 8:36 1 year ago 569 Далее Скачать
Alnuctamab, a BCMA x CD3 TCE, in the treatment of multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:02 9 months ago 107 Далее Скачать
First-in-Human Study of TNB-383B, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in Pts w/RRMM International Myeloma Foundation 4:28 2 years ago 254 Далее Скачать
Teclistamab, a BCMA × Cd3 Bispecific Antibody, in Pts with RRMM: Updated Phase 1 Results International Myeloma Foundation 9:57 3 years ago 1 155 Далее Скачать
Interim results for BCMA T-cell engager alnuctamab (CC-93269) in RRMM VJHemOnc – Video Journal of Hematology & HemOnc 2:24 4 years ago 78 Далее Скачать
Efficacy and safety of elranatamab BCMA-CD3 bispecific antibody, in patients with RRMM International Myeloma Foundation 7:06 3 years ago 1 088 Далее Скачать
Phase I study of teclistamab, a humanized BCMA x CD3 bispecific antibody, in relapsed/refractory MM International Myeloma Foundation 3:44 4 years ago 702 Далее Скачать
Phase I first-in-human study of alnuctamab in patients with R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:29 1 year ago 147 Далее Скачать
Updated phase 1 results of teclistamab, a BCMA × CD3 bispecific antibody, in RRMM International Myeloma Foundation 7:25 3 years ago 411 Далее Скачать
Phase I trial of a BCMA-CD3 bispecific antibody in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:20 3 years ago 148 Далее Скачать
Subcutaneous alnuctamab in patients with R/R multiple myeloma: the results of a Phase I trial VJHemOnc – Video Journal of Hematology & HemOnc 2:46 10 months ago 158 Далее Скачать
Teclistamab: BCMA x CD3 bispecific antibody in RRMM VJHemOnc – Video Journal of Hematology & HemOnc 3:41 4 years ago 801 Далее Скачать
REGN5459, a BCMA×CD3 bispecific antibody, in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 5:28 1 year ago 171 Далее Скачать
SC vs. IV administration of a BCMA-CD3 bispecific antibody for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:30 3 years ago 133 Далее Скачать
ASH23: Abbv-383 BCMA x CD3 Bispecific Antibody for Relapsed/Refractory Myeloma | Ravi Vij, MD, MBA International Myeloma Foundation 7:44 10 months ago 239 Далее Скачать
Phase I study of ABBV-383, a BCMA×CD3 bispecific antibody, in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:14 1 year ago 112 Далее Скачать
Exciting results for BCMA/CD3 bispecific elranatamab (PF-3135) in R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 3:34 4 years ago 680 Далее Скачать
B-cell maturation antigen targeted CD3-engaging bispecific molecule for relapsed or refractory m... ecancer 3:53 3 years ago 25 Далее Скачать
MagnetisMM-3: elranatamab in relapsed/refractory multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 10:39 2 years ago 548 Далее Скачать
